期刊文献+

凝胶包埋大鼠肝细胞用于醋氨酚肝毒性研究 被引量:2

Test on hepatotoxicity of acetaminophen using gel entrapment culture of rat hepatocytes
下载PDF
导出
摘要 以传统的多孔板贴壁培养为比较对象,采用醋氨酚为肝毒性药物模型,评价胶原凝胶包埋培养大鼠肝细胞用于药物肝毒性研究的可行性.结果发现,虽然多孔板培养和凝胶包埋培养肝细胞均表现出对醋氨酚肝毒性的浓度依赖性,但前者对毒性的敏感程度比后者小得多.在同样低浓度(2.5 mmol/L)的醋氨酚作用24 h后,胶原凝胶包埋的细胞活率下降到了对照组的35%,单层贴壁培养细胞的活率仅下降到了对照组的88%;以尿素和白蛋白合成能力表征的肝功能也出现同样趋势.此外,N-乙酰半胱氨酸(NAC)与甘草酸(GA)与醋氨酚一起加到培养基中能显著抑制醋氨酚导致的肝毒性,进一步说明凝胶包埋培养肝细胞可以反映保肝药物的临床作用. Compared with monolayer culture, collagen gel entrapment culture of hepatoeytes was evaluated as a hepatotoxicity model through testing on the hepatotoxicity of acetaminophen. Although both hepatocyte cultures showed concentration-dependent hepatotoxicity of acetaminophen, monolayer hepatocytes were less sensitive than gel entrapped hepatocytes. When exposed to the same low concentration of acetaminophen (2.5 mmol/L) for 24 h, gel entrapped hepatocytes presented much lower viability than monolayer hepatocytes and similar trend existed in urea genesis and albumin synthesis. Moreover, addition of N-acetylcysteine or glycyrrhizic acid together with acetaminophen reduced the hepatotoxicity of acetaminophen, which illustrated the feasibility of gel entrapment culture of hepatocytes as a hepatotoxicity model to reflect the situation of a hepatoprotective drug in vivo.
出处 《浙江大学学报(工学版)》 EI CAS CSCD 北大核心 2007年第4期700-704,共5页 Journal of Zhejiang University:Engineering Science
基金 国家自然科学基金资助项目(90209053) 浙江省教委资助项目(20040244) 浙江测试基金资助项目(04169)
关键词 体外肝细胞 凝胶培养 醋氨酚 肝毒性 hepatocyte gel entrapment culture acetaminophen hepatotoxicity
  • 相关文献

参考文献16

  • 1LAGADIC-GOSSMANN D,RISSEL M,LE BOT M A,et al.Toxic effects of tacrine on primary hepatocytes and liver epithelial cells in culture[J].Cell Biological Toxicology,1998,14(5):361-373.
  • 2HARAAUCHI T,HIRATA M.Effect of P-450 inducers on glutathione (GSH) depletion by bromobenzene in primary culture of dog hepatocytes[J].Biological Pharmacology Bulletin,1994,17(5):658-661.
  • 3HU W S,FRIEND J R,WU F J,et al.Development of a bioartificial liver employing xenogeneic hepatocytes[J].Cytotechnology,1997,23:29-38.
  • 4GUILLOUZO A.Liver cell models in in vitro toxicology[J].Environmental Health Perspectives,1998,106:511-532.
  • 5ROBERTS R A,SOAMES A R.Hepatocyte spheroids:prolonged hepatocyte viability for in vitro modeling of nongenotoxic carcinogenesis[J].Fundamental and Applied Toxicology,1993,21:149-158.
  • 6GEORGE E,HAMILTON G,WESTMORELAND C.The use of in vitro models in hepatotoxicity testing[J].Toxicology and Ecotoxicology News,1996,3(5):142-152.
  • 7NYBERG S L,SHATFORD R A,PESHWA M V,et al.Evaluation of a hepatocyte-entrapment hollow fiber bioreactor:a potential bioartificial liver[J].Biotechnology and Bioengineering,1993,41:194-203.
  • 8VINAYAK P H,LINDA K H,GREGORY J B,et al.Evaluation of the effect of culture matrices on induction of CYP3A isoforms in cultured porcine hepatocytes[J].Chemico-Biological Interactions,2000,127:91-106.
  • 9Dan-QingWu,Guo-LiangZhang,ChongShen,QianZhao,HuiLi,QinMeng.Evaluation of diffusion in gel entrapment cell culture within hollow fibers[J].World Journal of Gastroenterology,2005,11(11):1599-1604. 被引量:4
  • 10HUVENEERS-OORSPRONG M B M,HOOGENBOOM L A P,KUIPER H A.The use of the MTT test for determining the cytotoxicity of veterinary drugs in pig hepatocytes[J].Toxicology in Vitro,1997,11(4):385-392.

二级参考文献31

  • 1Uludag H, Vos PD, Tresco PA. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev 2000; 42: 29-64.
  • 2Jauregui HO, Chowdhury NR, Chowdhury JR. Use of mammalian cells for artificial liver support. Cell Transplant 1996; 5: 353-367.
  • 3Gloeckner H, Lemke HD. New miniaturized hollow-fiber bioreactor for in vivo like cell culture, cell expansion, and production of cell-derived products. Biotechnol Prog 2001; 17: 828-831.
  • 4Luque S, Mallubhotla H, Gehlert G, Kuriyel R, Dzengeleski S, Pearl S, Belfort G. A new coiled hollow-fiber module design for enhanced microfiltration performance in biotechnology. Biotechnol Bioeng 1999; 65: 247-257.
  • 5Wolf CF, Lauffer LL. Design and fabrication of a capillary cell culture chamber for the study of convective flow. Int J Artif Organs 1986; 9: 25-32.
  • 6Piret JM, Cooney CL. Immobilized mammalian cell cultivation in hollow fiber bioreactors. Biotechnol Adv 1990; 8: 763-783.
  • 7Nyberg SL, Shatford RA, Peshwa MV, White JG, Cerra FB, Hu WS. Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: A potential bioartificial liver. Biotechnol Bioeng 1993; 41: 194-203.
  • 8Sielaff TD, Hu MY, Amiot B, Rollins MD, Rao S, Mcguire B, Bloomer JR, Hu WS, Cerra FB. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res 1995; 59: 179-184.
  • 9Jauregui HO, Muller TE. Long-term cultures of adult mammalian hepatocytes in hollow fibers as the cellular component of extracorporeal (hybrid) liver assist devices. Artif Organs 1992; 16: 209-212.
  • 10Stanness KA, Guatteo E, Janigro D. A dynamic model of the blood-brain barrier in vitro. Neurotoxicology 1996; 17: 481-496.

共引文献325

同被引文献50

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部